As of 2024-12-15, the Intrinsic Value of Exact Sciences Corp (EXAS) is
4.97 USD. This EXAS valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 61.25 USD, the upside of Exact Sciences Corp is
-91.90%.
The range of the Intrinsic Value is 1.66 - 8.51 USD
EXAS Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(88.02) - (36.70) |
(48.76) |
-179.6% |
| DCF (Growth 10y) |
(31.89) - (65.00) |
(39.76) |
-164.9% |
| DCF (EBITDA 5y) |
1.66 - 8.51 |
4.97 |
-91.9% |
| DCF (EBITDA 10y) |
5.58 - 18.82 |
11.71 |
-80.9% |
| Fair Value |
-5.78 - -5.78 |
-5.78 |
-109.44% |
| P/E |
(28.10) - (35.99) |
(34.52) |
-156.4% |
| EV/EBITDA |
(2.13) - 9.96 |
4.19 |
-93.2% |
| EPV |
(41.12) - (50.97) |
(46.05) |
-175.2% |
| DDM - Stable |
(12.03) - (41.86) |
(26.94) |
-144.0% |
| DDM - Multi |
(6.73) - (18.13) |
(9.81) |
-116.0% |
EXAS Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
11,336.15 |
| Beta |
-0.26 |
| Outstanding shares (mil) |
185.08 |
| Enterprise Value (mil) |
13,330.65 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.61% |
| Cost of Debt |
5.50% |
| WACC |
7.99% |